SCHWINNNG Herbal Dietary Supplement Recalled for Undeclared Nortadalafil Content
SCHWINNNG Herbal Dietary Supplement (Lot #2108, exp. 10/31/2024) is recalled nationwide because it contains undeclared nortadalafil, an active pharmaceutical ingredient used for male sexual enhancement. The FDA classified this as an unapproved drug.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This product is classified as FDA Class I, which requires a minimum severity score of 4. While no reported illnesses or injuries are documented in the source text, the presence of an undeclared active pharmaceutical ingredient makes this a serious public health concern due to potential drug interactions and unknown effects.
Plain-English summary
SCHWINNNG Herbal Dietary Supplement, packaged in 10 capsules per box, is being recalled. The product was distributed by Today The World LLC, based in Vancouver, Washington. The recall involves 11,500 boxes with Lot #2108, with an expiration date of 10/31/2024. The product was distributed nationwide within the United States.
The FDA analysis found that this product contains undeclared nortadalafil, an active ingredient used in FDA-approved products for male sexual enhancement. Because the ingredient was not disclosed and the product lacks FDA approval, it is classified as an unapproved drug.
Consumers who have purchased SCHWINNNG Herbal Dietary Supplement with Lot #2108 should stop using the product and consult their healthcare provider if they have any health concerns related to its use.
The recalled product
- Product
- SCHWINNNG Herbal Dietary Supplement, packaged in 10 capsules per box, Distributed by: Today the World LLC, Vancouver, WA 98683
- Manufacturer
- Today The World
- Category
- Drug — Dietary Supplement
- Hazard
- undeclared-ingredient
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2108
- Exp. Date 10/31/2024.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27